Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ALPINE IMMUNE SCIENCES, INC.
| Metric | ALPINE IMMUNE SCIENCES, INC. Healthcare |
|---|---|
| Quality Score | 47 / 100 |
| Revenue (latest) | $59M |
| Net income (latest) | −$32M |
| Operating margin | −75.2% |
| Net margin | −54.7% |
| Return on equity | −9.8% |
| Return on assets | −8.5% |
| Return on capital (ROCE) | −13.1% |
| Debt / equity | 0.16× |
| Revenue growth (YoY) | 95.8% |
| Altman Z″ (distress) | 8.63 |
| Accruals / assets | 12.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.